🔎 Trials Near Me

Akèy › Kansè tete negatif triple › Oklahoma › Oklahoma City

Etid klinik pou Kansè tete negatif triple nan Oklahoma City, OK

9 etid pou Kansè tete negatif triple ap chèche patisipan nan sit nan ak bò kote Oklahoma City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Ap rekriteFaz 1/2
  • University of Oklahoma, Oklahoma City
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750

Study of AVZO-021 in Patients With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Avenzo Therapeutics Recruiting Site, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT05867251

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Ap rekriteFaz 1
  • Normunity Investigational Site, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07182149

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Ap rekriteFaz 1/2
  • University of Oklahoma - Health Sciences Center, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT05579366

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

Ap rekriteFaz 1/2
  • Stephenson Cancer Center Oklahoma University Health, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT05377996

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

Ap rekriteEtid obsèvasyon
  • Mercy Hospital - OKC, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT07327489

Study of XB010 in Subjects With Solid Tumors

Ap rekriteFaz 1
  • Stephenson Cancer Center, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Jun 22, 2026 · NCT06545331

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Ap rekriteFaz 1
  • Dren Investigational Site, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Jan 7, 2026 · NCT06999187

A Study of NX-1607 in Adults With Advanced Malignancies

Ap rekriteFaz 1
  • University of Oklahoma, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT05107674

Etid Kansè tete negatif triple nan lòt vil

Lòt etid nan Oklahoma City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.